WO1997039720A1 - Container closure system - Google Patents

Container closure system Download PDF

Info

Publication number
WO1997039720A1
WO1997039720A1 PCT/US1997/005882 US9705882W WO9739720A1 WO 1997039720 A1 WO1997039720 A1 WO 1997039720A1 US 9705882 W US9705882 W US 9705882W WO 9739720 A1 WO9739720 A1 WO 9739720A1
Authority
WO
WIPO (PCT)
Prior art keywords
wall
end portion
piercing member
stopper
piercing
Prior art date
Application number
PCT/US1997/005882
Other languages
French (fr)
Inventor
Steven P. Hellstrom
Peter J. Karas
John C. Tanner
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to AU26627/97A priority Critical patent/AU720748B2/en
Priority to JP53811597A priority patent/JP2000508934A/en
Priority to CA 2252404 priority patent/CA2252404A1/en
Priority to EP19970918544 priority patent/EP0895466A1/en
Publication of WO1997039720A1 publication Critical patent/WO1997039720A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1412Containers with closing means, e.g. caps
    • A61J1/1418Threaded type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00Special receptacle or package
    • Y10S206/828Medicinal content
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S215/00Bottles and jars
    • Y10S215/03Medical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S604/00Surgery
    • Y10S604/905Aseptic connectors or couplings, e.g. frangible, piercable

Definitions

  • the present invention is directed to a system for containing and delivering a fluid. More particularly, the present invention is directed to a closure system that permits the introduction and withdrawal of fluid from a container using an instrument having a blunt, luer-type connector.
  • Many pharmaceutical products are delivered to pharmacies in sealed containers such as vials, glass or plastic bottles, and flexible bags.
  • Such containers can contain a powdered or lyophilized formulation of a pharmaceutical product that must be reconstituted prior to administration to a patient.
  • such containers can contain a solution formulation of a pharmaceutical product that can be withdrawn from the container and administered directly to a patient, for example, by parenteral administration.
  • the piercing of vial stoppers typically has been achieved through the use of sharp, small-bored needles.
  • Standard hypodermic needles are particularly useful for this purpose because they allow the pharmaceutical product to be aseptically withdrawn from the vial and parenterally administered directly to a patient using a single device, thereby minimizing the risk of contamination of the pharmaceutical product.
  • hypodermic needles pose a risk of inadvertent needle sticks to medical professionals. Due to growing concerns regarding the possible transmission of HIV and other diseases through needle sticks, there has been a significant trend away from the use of hypodermic needles.
  • U.S. Patent No. 5,171,214 discloses a system having a cannula surrounded by a protective skirt assembly, thereby reducing the possibility of an inadvertent needle stick.
  • Other systems employ pre-slit stoppers that can be pierced using blunt cannulas, thereby obviating the need for a hypodermic needle.
  • Still other systems such as that disclosed in U.S. Patent No. 2,342,215, permit blunt needle access to the contents of a vial through the use of a piercing member disposed within a stopper, the piercing member being activated through the application of an inwardly directed force using the blunt needle.
  • the system of the present invention provides a closure system for a container.
  • the system includes a stopper having a lower surface configured to seal fluidly a container.
  • a closure member is mounted on an upper surface of the stopper.
  • the closure member includes a base, a lower surface of which is configured to engage the upper surface of the stopper.
  • the closure member further includes an inner wall and an outer wall extending from an upper surface of the base, the inner wall being spaced from the outer wall.
  • a needle access port is defined through the base of the closure member at a position between the inner and outer walls.
  • an aperture is defined through the base at a position adjacent to a chamber defined by the inner wall.
  • the system further includes a piercing member that is movably disposed within the chamber defined by the inner wall.
  • the piercing member has a first end portion and a second end portion.
  • a piercing tip is mounted on the first end portion, the piercing tip being configured to pierce the stopper.
  • the second end portion is configured to engage a luer inserted into the chamber defined by the inner wall.
  • a channel is defined through the piercing member such that fluid can be moved therethrough.
  • the closure system includes a stopper having a lower surface configured to seal fluidly a container.
  • a closure member is mounted on an upper surface of the stopper.
  • the closure member includes a base, a lower surface of which is configured to engage the upper surface of the stopper.
  • the closure member further includes a wall extending from an upper surface of the base. The wall defines a chamber therein. An aperture is defined through the base at a position adjacent to the chamber defined by the wall.
  • the system also includes a piercing member movably disposed within the chamber defined by the wall.
  • the piercing member has a first end portion and a second end portion.
  • a piercing tip is mounted on the first end portion, the piercing tip being configured to pierce the stopper.
  • the second end portion of the piercing member is configured to engage a luer inserted into the chamber defined by the wall.
  • a channel is defined through the piercing member such that fluid can be moved therethrough.
  • the system further includes a sealing member fluidly sealing the chamber defined by the wall.
  • FIGURE 1 is a cross- sectional view of a first embodiment of a container closure system constructed in accordance with the present invention
  • FIGURE 2 is a top view of the first embodiment of a container closure system constructed in accordance with the present invention
  • FIGURE 3 is an elevational view of a piercing member and a luer connector constructed in accordance with the present invention
  • FIGURE 4 is a cross-sectional view of a second embodiment of a container closure system constructed in accordance with the present invention.
  • FIGURE 5 is a top view of the second embodiment of a container closure system constructed in accordance with the present invention.
  • FIGURE 6 is a cross-sectional view of the second embodiment of a container closure system constructed in accordance with the present invention in which the piercing member is in fluid contact with the interior of the container.
  • a container closure system constructed in accordance with the present invention is generally indicated at 10 of FIG. 1.
  • System 10 is configured to seal fluidly container 12.
  • container 12 can be a pharmaceutical vial of known construction.
  • system 10 can be adapted to seal a wide variety of containers.
  • the depiction herein of a pharmaceutical vial is not intended to be limiting, but instead represents one useful application of the system of the present invention.
  • Container 12 also can be a plastic or glass bottle or a flexible bag of known construction.
  • all references to container 12 include vials, bottles, and flexible containers.
  • container 12 is a vial and includes an upper end portion 14 having a neck portion 16 and an upper surface 18.
  • Container 12 can be constructed of a variety of known materials using manufacturing techniques that form no part of the instant invention.
  • System 10 includes stopper 20 having lower surface 22 and upper surface 24. Lower surface 22 is configured to seal fluidly container 12. It will be appreciated that the configuration of stopper 20 will vary depending upon the nature and configuration of the container which it seals.
  • stopper 20 can be a pierceable membrane or plug configured to seal fluidly a port formed through a bottle, a flexible bag, or a vial.
  • stopper 20 can be a pierceable membrane covering apertures and needle access ports constructed in accordance with the present invention, as discussed in detail herein.
  • lower surface 22 is configured to engage upper surface 18 of container 12 where container 12 is a vial.
  • stopper 20 includes plug portion 26 extending from lower surface 22.
  • plug portion 26 can be an annular wall.
  • Plug portion 26 preferably has an outside dimension that is equal to or greater than an inner dimension of container 12, thereby providing a fluid-tight seal between plug portion 26 and container 12.
  • Stopper 20 can be constructed of a variety of materials, provided that the material used is pierceable, as discussed in detail herein, and provided the material is capable of sealing fluidly container
  • stopper 20 can be constructed of an elastomeric material having a capacity to provide a fluid-tight seal for container 12.
  • lower surface 22 of stopper 20 as depicted in FIG. 1, includes plug portion 26, it will be appreciated that various configurations of stopper 20 can be used in connection with the system of the present invention without departing from the intended spirit and scope of the invention as set forth in the appended claims.
  • lower surface 22 of stopper 20 can be substantially planar.
  • Stopper 20 also can be in the form of a film seal which fluidly seals container 12.
  • elastomeric and metallic seals of known construction can be used to provide the requisite fluid-tight seal.
  • stopper 20 is preferably sealed against upper surface 18 of container 12 using known sealing methods, e.g., adhesives, thereby facilitating the sealing process. In some cases it may be preferable that stopper 20 is peelable from upper surface 18 of container 12.
  • stopper 22 is configured to seal fluidly apertures and needle access ports formed through a container closure member constructed in accordance with the present invention
  • stopper 22 is preferably sealed to the closure member about the peripheries of each of the apertures and needle access ports.
  • the thickness of stopper 20 is reduced by indentation 32 formed in upper surface 24 of stopper 20.
  • indentation 32 will be discussed in detail herein. It will be appreciated that a reduction in the thickness of stopper 20 also can be achieved by the formation of an indentation on lower surface 22, or by indentations on both lower surface 22 and upper surface 24.
  • System 10 of the present invention further includes closure member 34 mounted on stopper 20.
  • Closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive or by way of a mechamcal attachment such as a threaded attachment, or formed from separate, unbonded members without departing from the intended spirit and scope of the invention claimed herein.
  • closure member 34 includes base 36 having lower surface 38 and upper surface 40. Lower surface 38 is configured to contact upper surface 24 of stopper 20.
  • Closure member 34 can be constructed of a variety of known materials, including flexible plastics, rigid plastics, and metals.
  • outer wall 42 and inner wall 44 extend from upper surface 40 of base 36.
  • Outer wall 42 is spaced from inner wall 44 such that walls 42, 44 define a space 46 therebetween.
  • walls 42, 44, and space 46 are annular in cross-section.
  • walls 42, 44 can have a variety of shapes without departing from the intended spirit and scope of the present invention as claimed herein.
  • space 46 is annular.
  • the heights of walls 42 and 44 can be either the same or different. In the embodiment depicted in FIG. 1, the height of outer wall 42 is greater than the height of inner wall 44.
  • base 36 of closure member 34 defines therethrough one or more needle access ports 48 between walls 42, 44. It will be appreciated that the upper surface of stopper 20 is exposed to space 46 through needle access port 48, thereby enabling the withdrawal of fluid from container 12 using a hypodermic needle by inserting the needle through needle access port 48 and through stopper 20.
  • Inner wall 44 defines therein chamber 52.
  • chamber 52 is circular in cross-section.
  • Base 36 defines therethrough aperture 50 at the base of chamber 52 defined by inner wall 44, thereby providing direct access from chamber 52 to stopper 20 through aperture 50.
  • aperture 50 is adjacent to indentation 32 formed in upper surface 24 of stopper 20.
  • Inner wall 44 has an inner surface 53 and an outer surface 55.
  • Inner wall 44 of the preferred embodiment of the present invention can have a variety of configurations, including cylindrical, conical, and combinations of cylindrical and conical configurations.
  • inner surface 53 of inner wall 44 also can be cylindrical, conical, or a combination of cylindrical and conical.
  • inner wall 44 and inner surface 53 thereof can have a variety of configurations without departing from the scope of the present invention.
  • inner surface 53 is dimensioned and configured to provide a frictional, substantially fluid-tight seal with an outer surface of luer 63 when luer 63 is inserted into chamber 52.
  • Luers 63 currently used in the medical field typically conform to national and international standards and are configured either for slip or locking engagement. Male and female luers are tapered in order to provide a frictional fit therebetween.
  • at least a portion of inner surface 53 of inner wall 44 is conically shaped and is tapered in the direction of aperture 50 to provide a frictional, preferably fluid-tight fit with an outer surface of luer 63.
  • the degree of taper of inner surface 53 of inner wall 44 is selected to match the taper of the male luer connector, thereby providing the desired sealing fit with the outer surface of luer 63 when luer 63 is inserted into chamber 52.
  • outer surface 55 of inner wall 44 is configured to be releasably lockable to luer 63, thereby preventing luer 63 from being forced outwardly relative to chamber 52 when air is injected into container 12 or when container 12 is pre-pressurized. Locking engagement between luer 63 and outer surface 53 can be provided using a variety of known techniques, including threads and collars. In the embodiment of the present invention depicted in FIG.
  • outer surface 55 includes threadable member 57 which permits a threaded luer 63 to be threadably secured thereto.
  • a single thread is provided on outer surface 55.
  • threads can be provided at any position along outer surface 55, or along the entirety of outer surface 55, in order to provide the capacity to threadably secure luer 63 thereto.
  • luer 63 can be selectively, threadingly released from outer surface 55 in these embodiments of the present invention when luer 63 is to be withdrawn from inner wall 44.
  • Outer surface 55 alternatively can be configured to provide a snap fit with luer 63 such that luer 63 is releasably retained on outer surface 55. Such a snap fit can be provided by forming a collar on outer surface 53 of inner wall 44. It will be appreciated by one of ordinary skill in the art that various other mechanisms for maintaining the position of luer 63 with respect to inner wall 44 are possible.
  • Piercing member 54 is movably disposed within chamber 52 defined by inner wall 44. As depicted in FIG. 3, piercing member 54 includes first end portion 56 positioned proximally to stopper 20 and second end portion 58 positioned distally to stopper 20. Piercing tip 60 is mounted on first end portion 56 of piercing member 54. Piercing tip 60 can be integrally formed on piercing member 54, or piercing tip 60 can be attached to first end portion 56 of piercing member 54 through the use of known methods of adhesive or mechanical attachment. Second end portion 58 of piercing member 54 is configured to engage luer 63.
  • second end portion 58 includes end surface 58a which is adapted to engage a terminal end of luer 63 in end-to-end abutment when luer 63 is inserted into chamber 52.
  • a male-female connection between piercing member 54 and luer 63 is not necessary in the preferred embodiment of the present invention due to the fact that there is a frictional, substantially fluid-tight connection between luer 63 and inner wall 44.
  • the preferred embodiment reduces the possibility that piercing member 54 will be rotated by rotation of luer 63, thereby reducing the possibility that stopper 22 will be cored by rotation of piercing member 54.
  • Second end portion 58 of piercing member 54 can alternatively be configured to receive a male luer connector therein when luer 63 is a male luer connector. Second end portion 58 also can be configured to mate with a female luer connector when luer 63 is a female luer connector. In an alternative embodiment, second end portion 58 of piercing member 54 can be flared such that luer 63 can be placed either in end-to-end abutment therewith or in male-female engagement therewith. Second end portion
  • 58 also can include a collar positioned about piercing member 54 where the collar is configured to provide either end-to-end abutment or male- female engagement with luer 63.
  • Piercing member 54 defines a channel 54A therethrough.
  • Channel 54A enables fluid to be drawn through piercing member 54 from first end portion 56 to second end portion 58 for the removal of fluid from container 12 through luer 63.
  • Channel 54A also enables fluid to be flowed through piercing member 54 from second end portion 58 to first end portion 56 for the introduction of fluid into container 12 from luer 63, e.g., during reconstitution of a lyophilized pharmaceutical product contained by container 12.
  • piercing member 54 frictionally engages inner surface 53 of inner wall 44.
  • This frictional fit can be provided by constructing piercing member 54 such that its outer diameter is substantially equal to an inner diameter of inner wall 44, by positioning a collar having a diameter that is substantially equal to an inner diameter of inner wall 44 on piercing member 54, or by placing a plurality of frictional nibs 59 on piercing member 54 where the diameter of piercing member 54 plus frictional nibs 59 is substantially equal to an inner diameter of inner wall 44.
  • inner wall 44 can be substantially the same as or different than the height of outer wall 42.
  • inner wall 44 and base 36 are configured such that either or both inner wall 44 and base 36 prevent luer 63 from forcing piercing member beyond a desired position relative to stopper 20 and container 12.
  • a stop can be placed on exterior surface 55 of inner wall 44 in order to stop the forward motion of luer 63.
  • piercing member 54 is configured such that it will not penetrate stopper 20 beyond a predetermined depth of penetration.
  • a collar can be provided on piercing member 54. It will be appreciated that the collar will not pass readily through stopper 20 and thereby will impede forward motion of luer
  • stopper 20 is pre-pierced in order to facilitate movement therethrough of piercing member 54.
  • piercing member 54 is mounted through stopper 20 such that first end portion 56 of piercing member 54 is in fluid contact with the contents of container 12.
  • piercing tip 60 can be omitted in this second alternative embodiment of the present invention due to the fact that piercing member 54 is mounted through stopper 20.
  • piercing member 54 can include a luer accessible valve of known construction.
  • Port 56A is defined through first end portion 56 of piercing member 54 and is in fluid communication with channel 54A defined through piercing member 54. In the embodiment depicted in FIG. 3, port 56A extends a predetermined distance along first end portion 56 from piercing tip 60. When piercing member 54 is forced through stopper 20, port 56A is in fluid communication with fluid within container 12. In a preferred embodiment of the present invention, piercing member 54 and port 56A are configured such that port 56 A extends at least from piercing tip 60 to a position substantially coincident with lower surface 22 of stopper 20 after piercing member 54 has been forced through stopper 20. In this way, substantially all fluid contained by container 12 can be withdrawn therefrom through piercing member 54, thereby reducing or eliminating waste. It will be appreciated that port 56A can have a variety of configurations without departing from the intended scope of the present invention.
  • Piercing member 54 preferably is configured such that it is retained by stopper 20 after piercing member 54 has been forced therethrough, thereby preventing piercing member 54 from being removed from closure member 34 when the luer 63 is removed from luer connection 62.
  • piercing member retainer 64 in the form of a collar on inner wall 44 is provided in order to ensure that piercing member 54 is not inadvertently withdrawn from chamber 52.
  • piercing member retainer 64 can have a variety of configurations.
  • piercing member retainer 64 can be disposed on first end portion 56 of piercing member 54.
  • piercing member retainer 64 is constructed such that it is able to pass through stopper 20 and into container 12 but thereafter cannot be withdrawn from stopper 20, thereby securing piercing member 54 to stopper 20.
  • indentation 32 defined by stopper 20 receives first end portion 56 of piercing member 54.
  • Indentation 32 serves to orient and guide piercing member 54 with respect to stopper 20.
  • indentation 32 reduces the thickness of stopper 20 that must be pierced by piercing member 54, thereby reducing the force required to pierce stopper 20.
  • Sealing member 66 is configured for removable attachment to closure member 34. Sealing member 66 can have a variety of configurations. In one embodiment, mating threads 68, 70 are formed on closure member 34 and sealing member 66, respectively, whereby sealing member 66 can be threadably secured to and removed from closure member 34.
  • sealing member 66 can be threadably secured to and removed from container 12.
  • sealing member 66 is configured to provide a frictional or snap fit with closure member 34.
  • sealing member 66 is a peelable, preferably fluid-impervious membrane removably attached to closure member 34. Sealing member 66 may also include a tamper band.
  • sealing member 66 fluidly seals both outer wall 42 and inner wall 44 of closure member 34. In this way, chamber 52 defined by inner wall 44 remains fluidly isolated from space 46 when sealing member 66 is attached to closure member 34. However, in some cases it may not be necessary to isolate fluidly chamber 52 from space 46. Thus, sealing member 66 may also be constructed to seal fluidly only outer wall 42, thereby fluidly isolating the contents of container 12 from the external environment but not fluidly isolating chamber 52 from space 46. Sealing member 66 can be connected to closure member 34 to provide a flip-top seal, or sealing member 66 can be separate from closure member 34. Sealing member 66 preferably provides a sterile seal of closure member 34.
  • closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive, or formed from separate, unbonded members without departing from the intended scope of the invention claimed herein.
  • closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive, or formed from separate, unbonded members without departing from the intended scope of the invention claimed herein.
  • closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive, or formed from separate, unbonded members without departing from the intended scope of the invention claimed herein.
  • closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive, or formed from separate, unbonded members without departing from the intended scope of the invention claimed herein.
  • closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive, or formed from separate, unbonded members without departing from the intended scope of the invention claimed herein.
  • ferrule 72 is provided to secure closure member 34 and stopper 20 to container 12.
  • Ferrule 72 includes first leg 74 and second leg 76 configured to grasp upper surface 40 and neck 16, respectively. Ferrule 72 thus retains container closure 34 and stopper 20 against upper surface 18 of container 12.
  • ferrule 72 can be configured to urge closure member 34 toward container 12, thereby compressing stopper 20 between closure member 34 and container 12, and thereby facilitating a fluid-tight seal between stopper 20 and container 12.
  • Ferrule 72 can be constructed of a variety of known materials, including soft metals, such as aluminum, and plastics.
  • container 12 and stopper 20 are constructed as above-discussed with respect to the first embodiment of the present invention depicted in FIG. 1.
  • This embodiment further includes closure member 134 having base 136.
  • Base 136 has lower surface 138 configured to contact upper surface 24 of stopper 20.
  • Base 136 further includes upper surface 140.
  • Wall 144 extends upwardly from upper surface 140 and defines a chamber 152 therein.
  • the configuration of wall 144 and its cooperation with a luer are the same as above-discussed in detail with respect to luer 63 and wall 44 of the embodiment of the present invention depicted in FIG. 1.
  • Base 136 defines therethrough an aperture 150 at a position adjacent to chamber 152.
  • Aperture 150 provides direct access to stopper 20 from chamber 152.
  • stopper 20 includes indentation 32 defined by upper surface 24 of stopper 20.
  • Piercing member 54 constructed in accordance with the description of the embodiment of the present invention depicted in FIG. 3, is movably disposed within chamber 152 of the embodiment of the present invention depicted in FIG. 4.
  • Sealing member 166 fluidly seals chamber 152 from an external environment of system 10.
  • Sealing member 166 can have any of the configurations above-discussed with respect to sealing member 66 depicted in FIG. 1. As depicted in FIG. 4, sealing member 166 can be a peelable membrane.
  • Ferrule 72 constructed in accordance with the description of the embodiment of the present invention depicted in FIG. 1, retains closure member 134 and stopper 20 on container 12 as above-discussed.
  • Sealing member 66 is removed from closure member 34, thereby exposing the interior of closure member 34.
  • a medical professional can then access the contents of container 12 in one of two ways. First, the medical professional can withdraw fluid from container 12 using a sharp catheter, e.g., a hypodermic needle, by inserting the needle through needle access port 48 and piercing stopper 20. After insertion of the needle into container 12, fluid is drawn into the needle and the needle is withdrawn from stopper 20 through needle access port 48. Subsequent withdrawals of fluid from container 12 can be made using a needle by following the same sequence of steps.
  • a sharp catheter e.g., a hypodermic needle
  • a medical professional will use a device having luer 63 mounted thereon.
  • Luer 63 is inserted into chamber 52.
  • inner wall 44 and wall 144 are preferably configured to provide a fluid-tight seal with the exterior surface of luer 63 when luer 63 is inserted therein.
  • the medical professional then applies pressure to luer 63 such that it engages piercing member 54 and forces piercing member 54 toward container 12, thereby causing piercing tip 60 to penetrate stopper 20.
  • the contents of container 12 are in fluid communication with piercing member 54 which in turn is in fluid communication with luer 63.
  • luer 63 and the exterior surfaces of inner wall 44/wall 144 are threaded, luer 63 can be threadably secured to inner wall 44/wall 144.
  • the medical professional then can inject fluid into container 12 and/or withdraw fluid from container 12 through piercing member 54 by operation of luer 63 and a syringe attached thereto.
  • the luer 63 is withdrawn from inner wall 44, wall 144.
  • stopper 20 and piercing member 54 preferably are constructed such that piercing member 54 is not withdrawn from stopper 20 when luer 63 is withdrawn from the inner wall 44/wall 144.
  • piercing member retainer 64 will prevent piercing member 54 from being removed from chamber 52.
  • FIG. 1 allows a medical professional to access the contents of container 12 using either a sharp cannula or a device having luer 63 mounted thereon.
  • the embodiment of the system of the present invention depicted in FIG. 4 allows a medical professional to access the contents of container 12 using only a device having luer 63 mounted thereon.
  • the embodiment of the system of the present invention depicted in FIG. 3 can be modified to include one or more needle access ports 48 defined by base 136 of closure member 134, thereby providing direct access to stopper 20.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Closures For Containers (AREA)

Abstract

A container closure system for delivering a fluid. The system includes a stopper constructed to seal fluidly a container. A closure member is mounted on an upper surface of the stopper. The closure member includes a base having an upper surface and a lower surface. The closure member further includes an outer wall and an inner wall extending from the upper surface of the base with the inner wall spaced from the outer wall. The base defines therethrough a needle access port between the inner and outer walls. The inner wall defines a chamber therein. The base further defines therethrough an aperture adjacent the chamber defined by the inner wall. A piercing member is movably disposed within the chamber defined by the inner wall. The piercing member has a first end portion and a second end portion, the first end portion being positioned proximally to the stopper. A piercing tip is mounted on the first end portion and is constructed to pierce the stopper. The second end portion of the piercing member is configured to engage a luer inserted into the chamber defined by the inner wall. A channel is defined through the piercing member.

Description

CONTAINERCLOSURESYSTEM
Background of the Invention
The present invention is directed to a system for containing and delivering a fluid. More particularly, the present invention is directed to a closure system that permits the introduction and withdrawal of fluid from a container using an instrument having a blunt, luer-type connector. Many pharmaceutical products are delivered to pharmacies in sealed containers such as vials, glass or plastic bottles, and flexible bags. Such containers can contain a powdered or lyophilized formulation of a pharmaceutical product that must be reconstituted prior to administration to a patient. In addition, such containers can contain a solution formulation of a pharmaceutical product that can be withdrawn from the container and administered directly to a patient, for example, by parenteral administration. Most pharmaceutical vials are fluidly sealed by a pierceable stopper, thereby isolating the contents of the vial from the vial's external environment. In order to access the pharmaceutical product within the vial, it is necessary either to pierce the stopper or to remove the stopper from the vial. However, removal of the stopper results in exposure of the pharmaceutical product to the external environment of the vial, thereby compromising the sterility and/or stability of the pharmaceutical product within the vial. For this reason, it often is preferable to access the pharmaceutical product by piercing the stopper.
The piercing of vial stoppers typically has been achieved through the use of sharp, small-bored needles. Standard hypodermic needles are particularly useful for this purpose because they allow the pharmaceutical product to be aseptically withdrawn from the vial and parenterally administered directly to a patient using a single device, thereby minimizing the risk of contamination of the pharmaceutical product. However, hypodermic needles pose a risk of inadvertent needle sticks to medical professionals. Due to growing concerns regarding the possible transmission of HIV and other diseases through needle sticks, there has been a significant trend away from the use of hypodermic needles. In addition, in many cases it is necessary to clean the outer surface of the vial stopper prior to piercing in order to reduce the risk of infection to the patient. This requires the medical professional to perform two distinct steps in order to withdraw the pharmaceutical product from the vial.
Various systems have been developed in order to eliminate the use of hypodermic needles in reconstituting and/or withdrawing pharmaceutical products from vials. For example, U.S. Patent No. 5,171,214 discloses a system having a cannula surrounded by a protective skirt assembly, thereby reducing the possibility of an inadvertent needle stick. Other systems employ pre-slit stoppers that can be pierced using blunt cannulas, thereby obviating the need for a hypodermic needle. Still other systems, such as that disclosed in U.S. Patent No. 2,342,215, permit blunt needle access to the contents of a vial through the use of a piercing member disposed within a stopper, the piercing member being activated through the application of an inwardly directed force using the blunt needle.
Summary of the Invention
The system of the present invention provides a closure system for a container. The system includes a stopper having a lower surface configured to seal fluidly a container. A closure member is mounted on an upper surface of the stopper. The closure member includes a base, a lower surface of which is configured to engage the upper surface of the stopper. The closure member further includes an inner wall and an outer wall extending from an upper surface of the base, the inner wall being spaced from the outer wall. A needle access port is defined through the base of the closure member at a position between the inner and outer walls. In addition, an aperture is defined through the base at a position adjacent to a chamber defined by the inner wall. The system further includes a piercing member that is movably disposed within the chamber defined by the inner wall. The piercing member has a first end portion and a second end portion. A piercing tip is mounted on the first end portion, the piercing tip being configured to pierce the stopper. The second end portion is configured to engage a luer inserted into the chamber defined by the inner wall. A channel is defined through the piercing member such that fluid can be moved therethrough.
In an alternative embodiment of the present invention, the closure system includes a stopper having a lower surface configured to seal fluidly a container. A closure member is mounted on an upper surface of the stopper. The closure member includes a base, a lower surface of which is configured to engage the upper surface of the stopper. The closure member further includes a wall extending from an upper surface of the base. The wall defines a chamber therein. An aperture is defined through the base at a position adjacent to the chamber defined by the wall. The system also includes a piercing member movably disposed within the chamber defined by the wall. The piercing member has a first end portion and a second end portion. A piercing tip is mounted on the first end portion, the piercing tip being configured to pierce the stopper. The second end portion of the piercing member is configured to engage a luer inserted into the chamber defined by the wall. A channel is defined through the piercing member such that fluid can be moved therethrough. The system further includes a sealing member fluidly sealing the chamber defined by the wall.
Brief Description of the Drawings
For a more complete understanding of the present invention, reference may be had to the following Detailed Description read in connection with the accompanying drawings in which:
FIGURE 1 is a cross- sectional view of a first embodiment of a container closure system constructed in accordance with the present invention;
FIGURE 2 is a top view of the first embodiment of a container closure system constructed in accordance with the present invention; FIGURE 3 is an elevational view of a piercing member and a luer connector constructed in accordance with the present invention;
FIGURE 4 is a cross-sectional view of a second embodiment of a container closure system constructed in accordance with the present invention;
FIGURE 5 is a top view of the second embodiment of a container closure system constructed in accordance with the present invention; and
FIGURE 6 is a cross-sectional view of the second embodiment of a container closure system constructed in accordance with the present invention in which the piercing member is in fluid contact with the interior of the container.
Detailed Description
A container closure system constructed in accordance with the present invention is generally indicated at 10 of FIG. 1. System 10 is configured to seal fluidly container 12. As depicted in the attached figures, container 12 can be a pharmaceutical vial of known construction. However, it will be appreciated that system 10 can be adapted to seal a wide variety of containers. The depiction herein of a pharmaceutical vial is not intended to be limiting, but instead represents one useful application of the system of the present invention. Container 12 also can be a plastic or glass bottle or a flexible bag of known construction. For the purposes of this disclosure, all references to container 12 include vials, bottles, and flexible containers.
As depicted in FIG. 1, container 12 is a vial and includes an upper end portion 14 having a neck portion 16 and an upper surface 18. Container 12 can be constructed of a variety of known materials using manufacturing techniques that form no part of the instant invention. System 10 includes stopper 20 having lower surface 22 and upper surface 24. Lower surface 22 is configured to seal fluidly container 12. It will be appreciated that the configuration of stopper 20 will vary depending upon the nature and configuration of the container which it seals. For example, stopper 20 can be a pierceable membrane or plug configured to seal fluidly a port formed through a bottle, a flexible bag, or a vial. In addition, stopper 20 can be a pierceable membrane covering apertures and needle access ports constructed in accordance with the present invention, as discussed in detail herein.
In the embodiment of the present invention depicted in FIG. 1, lower surface 22 is configured to engage upper surface 18 of container 12 where container 12 is a vial. In addition, stopper 20 includes plug portion 26 extending from lower surface 22. As depicted in FIG. 1, plug portion 26 can be an annular wall. Plug portion 26 preferably has an outside dimension that is equal to or greater than an inner dimension of container 12, thereby providing a fluid-tight seal between plug portion 26 and container 12. Stopper 20 can be constructed of a variety of materials, provided that the material used is pierceable, as discussed in detail herein, and provided the material is capable of sealing fluidly container
12. For example, stopper 20 can be constructed of an elastomeric material having a capacity to provide a fluid-tight seal for container 12. Although lower surface 22 of stopper 20, as depicted in FIG. 1, includes plug portion 26, it will be appreciated that various configurations of stopper 20 can be used in connection with the system of the present invention without departing from the intended spirit and scope of the invention as set forth in the appended claims. For example, lower surface 22 of stopper 20 can be substantially planar.
Stopper 20 also can be in the form of a film seal which fluidly seals container 12. For example, elastomeric and metallic seals of known construction can be used to provide the requisite fluid-tight seal. In those embodiments of the present invention in which stopper 20 is a film seal, stopper 20 is preferably sealed against upper surface 18 of container 12 using known sealing methods, e.g., adhesives, thereby facilitating the sealing process. In some cases it may be preferable that stopper 20 is peelable from upper surface 18 of container 12. Further, in those embodiments of the present invention in which stopper 22 is configured to seal fluidly apertures and needle access ports formed through a container closure member constructed in accordance with the present invention, stopper 22 is preferably sealed to the closure member about the peripheries of each of the apertures and needle access ports. Various other modifications to the configuration of stopper 20 will be apparent to one of ordinary skill in the art.
In the embodiment of the present invention depicted in FIG. 1, the thickness of stopper 20 is reduced by indentation 32 formed in upper surface 24 of stopper 20. The utility of indentation 32 will be discussed in detail herein. It will be appreciated that a reduction in the thickness of stopper 20 also can be achieved by the formation of an indentation on lower surface 22, or by indentations on both lower surface 22 and upper surface 24.
System 10 of the present invention further includes closure member 34 mounted on stopper 20. Closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive or by way of a mechamcal attachment such as a threaded attachment, or formed from separate, unbonded members without departing from the intended spirit and scope of the invention claimed herein. In the embodiment of the present invention depicted in FIG. 1, closure member 34 includes base 36 having lower surface 38 and upper surface 40. Lower surface 38 is configured to contact upper surface 24 of stopper 20. Closure member 34 can be constructed of a variety of known materials, including flexible plastics, rigid plastics, and metals.
In the first embodiment of the present invention depicted in FIG. 1, outer wall 42 and inner wall 44 extend from upper surface 40 of base 36.
Outer wall 42 is spaced from inner wall 44 such that walls 42, 44 define a space 46 therebetween. In the embodiment of the present invention depicted in FIG. 1, walls 42, 44, and space 46 are annular in cross-section. However, it will be appreciated that walls 42, 44 can have a variety of shapes without departing from the intended spirit and scope of the present invention as claimed herein. In the depicted embodiment, space 46 is annular. The heights of walls 42 and 44 can be either the same or different. In the embodiment depicted in FIG. 1, the height of outer wall 42 is greater than the height of inner wall 44.
As depicted in FIG. 2, base 36 of closure member 34 defines therethrough one or more needle access ports 48 between walls 42, 44. It will be appreciated that the upper surface of stopper 20 is exposed to space 46 through needle access port 48, thereby enabling the withdrawal of fluid from container 12 using a hypodermic needle by inserting the needle through needle access port 48 and through stopper 20.
Inner wall 44 defines therein chamber 52. In the embodiment of the present invention depicted in the accompanying figures, chamber 52 is circular in cross-section. Base 36 defines therethrough aperture 50 at the base of chamber 52 defined by inner wall 44, thereby providing direct access from chamber 52 to stopper 20 through aperture 50. In the embodiment of the present invention depicted in FIG. 1, aperture 50 is adjacent to indentation 32 formed in upper surface 24 of stopper 20. Inner wall 44 has an inner surface 53 and an outer surface 55.
Inner wall 44 of the preferred embodiment of the present invention can have a variety of configurations, including cylindrical, conical, and combinations of cylindrical and conical configurations. In the preferred embodiment of the present invention, inner surface 53 of inner wall 44 also can be cylindrical, conical, or a combination of cylindrical and conical.
However, it will be appreciated that inner wall 44 and inner surface 53 thereof can have a variety of configurations without departing from the scope of the present invention.
In the preferred embodiment of the present invention, inner surface 53 is dimensioned and configured to provide a frictional, substantially fluid-tight seal with an outer surface of luer 63 when luer 63 is inserted into chamber 52. Luers 63 currently used in the medical field typically conform to national and international standards and are configured either for slip or locking engagement. Male and female luers are tapered in order to provide a frictional fit therebetween. Thus, in the preferred embodiment of the present invention, at least a portion of inner surface 53 of inner wall 44 is conically shaped and is tapered in the direction of aperture 50 to provide a frictional, preferably fluid-tight fit with an outer surface of luer 63. In the preferred embodiment, the degree of taper of inner surface 53 of inner wall 44 is selected to match the taper of the male luer connector, thereby providing the desired sealing fit with the outer surface of luer 63 when luer 63 is inserted into chamber 52. In an alternative embodiment of the present invention, outer surface 55 of inner wall 44 is configured to be releasably lockable to luer 63, thereby preventing luer 63 from being forced outwardly relative to chamber 52 when air is injected into container 12 or when container 12 is pre-pressurized. Locking engagement between luer 63 and outer surface 53 can be provided using a variety of known techniques, including threads and collars. In the embodiment of the present invention depicted in FIG. 1, outer surface 55 includes threadable member 57 which permits a threaded luer 63 to be threadably secured thereto. In one embodiment of the present invention, a single thread is provided on outer surface 55. In alternative embodiments of the present invention, threads can be provided at any position along outer surface 55, or along the entirety of outer surface 55, in order to provide the capacity to threadably secure luer 63 thereto. It will be appreciated that luer 63 can be selectively, threadingly released from outer surface 55 in these embodiments of the present invention when luer 63 is to be withdrawn from inner wall 44. Outer surface 55 alternatively can be configured to provide a snap fit with luer 63 such that luer 63 is releasably retained on outer surface 55. Such a snap fit can be provided by forming a collar on outer surface 53 of inner wall 44. It will be appreciated by one of ordinary skill in the art that various other mechanisms for maintaining the position of luer 63 with respect to inner wall 44 are possible.
Piercing member 54 is movably disposed within chamber 52 defined by inner wall 44. As depicted in FIG. 3, piercing member 54 includes first end portion 56 positioned proximally to stopper 20 and second end portion 58 positioned distally to stopper 20. Piercing tip 60 is mounted on first end portion 56 of piercing member 54. Piercing tip 60 can be integrally formed on piercing member 54, or piercing tip 60 can be attached to first end portion 56 of piercing member 54 through the use of known methods of adhesive or mechanical attachment. Second end portion 58 of piercing member 54 is configured to engage luer 63. In the preferred embodiment of the present invention depicted in the accompanying figures, second end portion 58 includes end surface 58a which is adapted to engage a terminal end of luer 63 in end-to-end abutment when luer 63 is inserted into chamber 52. A male-female connection between piercing member 54 and luer 63 is not necessary in the preferred embodiment of the present invention due to the fact that there is a frictional, substantially fluid-tight connection between luer 63 and inner wall 44. By eliminating the male- female luer connection between luer 63 and piercing member 54, the preferred embodiment reduces the possibility that piercing member 54 will be rotated by rotation of luer 63, thereby reducing the possibility that stopper 22 will be cored by rotation of piercing member 54.
Second end portion 58 of piercing member 54 can alternatively be configured to receive a male luer connector therein when luer 63 is a male luer connector. Second end portion 58 also can be configured to mate with a female luer connector when luer 63 is a female luer connector. In an alternative embodiment, second end portion 58 of piercing member 54 can be flared such that luer 63 can be placed either in end-to-end abutment therewith or in male-female engagement therewith. Second end portion
58 also can include a collar positioned about piercing member 54 where the collar is configured to provide either end-to-end abutment or male- female engagement with luer 63.
Piercing member 54 defines a channel 54A therethrough. Channel 54A enables fluid to be drawn through piercing member 54 from first end portion 56 to second end portion 58 for the removal of fluid from container 12 through luer 63. Channel 54A also enables fluid to be flowed through piercing member 54 from second end portion 58 to first end portion 56 for the introduction of fluid into container 12 from luer 63, e.g., during reconstitution of a lyophilized pharmaceutical product contained by container 12.
In the embodiment of the present invention depicted in FIG. 4, at least a portion of piercing member 54 frictionally engages inner surface 53 of inner wall 44. This frictional fit can be provided by constructing piercing member 54 such that its outer diameter is substantially equal to an inner diameter of inner wall 44, by positioning a collar having a diameter that is substantially equal to an inner diameter of inner wall 44 on piercing member 54, or by placing a plurality of frictional nibs 59 on piercing member 54 where the diameter of piercing member 54 plus frictional nibs 59 is substantially equal to an inner diameter of inner wall 44.
As above-indicated, the height of inner wall 44 can be substantially the same as or different than the height of outer wall 42. In one embodiment of the present invention, inner wall 44 and base 36 are configured such that either or both inner wall 44 and base 36 prevent luer 63 from forcing piercing member beyond a desired position relative to stopper 20 and container 12. In an alternative embodiment, a stop can be placed on exterior surface 55 of inner wall 44 in order to stop the forward motion of luer 63. In still another embodiment, piercing member 54 is configured such that it will not penetrate stopper 20 beyond a predetermined depth of penetration. For example, a collar can be provided on piercing member 54. It will be appreciated that the collar will not pass readily through stopper 20 and thereby will impede forward motion of luer
63 and piercing member 54 relative to stopper 20 beyond a predetermined position. One of ordinary skill in the art will appreciate that other types of stops can be placed on piercing member 54 in order to impede the forward motion of luer 63 and piercing member 54 relative to stopper 20. In an alternative embodiment of the present invention not depicted in the accompanying figures, stopper 20 is pre-pierced in order to facilitate movement therethrough of piercing member 54. In a second alternative embodiment of the present invention not depicted in the accompanying figures, piercing member 54 is mounted through stopper 20 such that first end portion 56 of piercing member 54 is in fluid contact with the contents of container 12. It will be appreciated that piercing tip 60 can be omitted in this second alternative embodiment of the present invention due to the fact that piercing member 54 is mounted through stopper 20. In this second alternative embodiment, piercing member 54 can include a luer accessible valve of known construction.
Port 56A is defined through first end portion 56 of piercing member 54 and is in fluid communication with channel 54A defined through piercing member 54. In the embodiment depicted in FIG. 3, port 56A extends a predetermined distance along first end portion 56 from piercing tip 60. When piercing member 54 is forced through stopper 20, port 56A is in fluid communication with fluid within container 12. In a preferred embodiment of the present invention, piercing member 54 and port 56A are configured such that port 56 A extends at least from piercing tip 60 to a position substantially coincident with lower surface 22 of stopper 20 after piercing member 54 has been forced through stopper 20. In this way, substantially all fluid contained by container 12 can be withdrawn therefrom through piercing member 54, thereby reducing or eliminating waste. It will be appreciated that port 56A can have a variety of configurations without departing from the intended scope of the present invention.
Piercing member 54 preferably is configured such that it is retained by stopper 20 after piercing member 54 has been forced therethrough, thereby preventing piercing member 54 from being removed from closure member 34 when the luer 63 is removed from luer connection 62. In one embodiment of the present invention, piercing member retainer 64 in the form of a collar on inner wall 44 is provided in order to ensure that piercing member 54 is not inadvertently withdrawn from chamber 52. However, it will be appreciated that piercing member retainer 64 can have a variety of configurations. For example, piercing member retainer 64 can be disposed on first end portion 56 of piercing member 54. In this embodiment, piercing member retainer 64 is constructed such that it is able to pass through stopper 20 and into container 12 but thereafter cannot be withdrawn from stopper 20, thereby securing piercing member 54 to stopper 20.
As depicted in FIG. 1, indentation 32 defined by stopper 20 receives first end portion 56 of piercing member 54. Indentation 32 serves to orient and guide piercing member 54 with respect to stopper 20. In addition, indentation 32 reduces the thickness of stopper 20 that must be pierced by piercing member 54, thereby reducing the force required to pierce stopper 20. Sealing member 66 is configured for removable attachment to closure member 34. Sealing member 66 can have a variety of configurations. In one embodiment, mating threads 68, 70 are formed on closure member 34 and sealing member 66, respectively, whereby sealing member 66 can be threadably secured to and removed from closure member 34. It will be appreciated that threads 68 can be formed on container 12 whereby sealing member 66 can be threadably secured to and removed from container 12. In a second embodiment, sealing member 66 is configured to provide a frictional or snap fit with closure member 34. In a third embodiment of the present invention depicted in FIG. 4, sealing member 66 is a peelable, preferably fluid-impervious membrane removably attached to closure member 34. Sealing member 66 may also include a tamper band.
In the embodiment of the present invention depicted in FIG. 1, sealing member 66 fluidly seals both outer wall 42 and inner wall 44 of closure member 34. In this way, chamber 52 defined by inner wall 44 remains fluidly isolated from space 46 when sealing member 66 is attached to closure member 34. However, in some cases it may not be necessary to isolate fluidly chamber 52 from space 46. Thus, sealing member 66 may also be constructed to seal fluidly only outer wall 42, thereby fluidly isolating the contents of container 12 from the external environment but not fluidly isolating chamber 52 from space 46. Sealing member 66 can be connected to closure member 34 to provide a flip-top seal, or sealing member 66 can be separate from closure member 34. Sealing member 66 preferably provides a sterile seal of closure member 34. The need to aseptically clean upper surface 24 of stopper 20 prior to use is obviated by maintaining the sterility of upper surface 24 of stopper 20 and piercing member 54 during storage, thereby reducing the labor associated with use of the system of the present invention. As above-discussed, closure member 34 and stopper 20 can be integrally formed, attached to one another, for example, by way of adhesive, or formed from separate, unbonded members without departing from the intended scope of the invention claimed herein. In the embodiment of the present invention depicted in FIG. 1, closure member
34 and stopper 20 are separate, unbonded elements. In this embodiment, ferrule 72 is provided to secure closure member 34 and stopper 20 to container 12. Ferrule 72 includes first leg 74 and second leg 76 configured to grasp upper surface 40 and neck 16, respectively. Ferrule 72 thus retains container closure 34 and stopper 20 against upper surface 18 of container 12. In the event that stopper 20 is constructed of an elastomeric material, ferrule 72 can be configured to urge closure member 34 toward container 12, thereby compressing stopper 20 between closure member 34 and container 12, and thereby facilitating a fluid-tight seal between stopper 20 and container 12. Ferrule 72 can be constructed of a variety of known materials, including soft metals, such as aluminum, and plastics.
In the embodiment of the present invention depicted in FIG. 4, container 12 and stopper 20 are constructed as above-discussed with respect to the first embodiment of the present invention depicted in FIG. 1. This embodiment further includes closure member 134 having base 136.
Base 136 has lower surface 138 configured to contact upper surface 24 of stopper 20. Base 136 further includes upper surface 140. Wall 144 extends upwardly from upper surface 140 and defines a chamber 152 therein. The configuration of wall 144 and its cooperation with a luer are the same as above-discussed in detail with respect to luer 63 and wall 44 of the embodiment of the present invention depicted in FIG. 1. Base 136 defines therethrough an aperture 150 at a position adjacent to chamber 152. Aperture 150 provides direct access to stopper 20 from chamber 152. As depicted in FIG. 4, stopper 20 includes indentation 32 defined by upper surface 24 of stopper 20.
Piercing member 54, constructed in accordance with the description of the embodiment of the present invention depicted in FIG. 3, is movably disposed within chamber 152 of the embodiment of the present invention depicted in FIG. 4. Sealing member 166 fluidly seals chamber 152 from an external environment of system 10. Sealing member 166 can have any of the configurations above-discussed with respect to sealing member 66 depicted in FIG. 1. As depicted in FIG. 4, sealing member 166 can be a peelable membrane.
Ferrule 72, constructed in accordance with the description of the embodiment of the present invention depicted in FIG. 1, retains closure member 134 and stopper 20 on container 12 as above-discussed.
Use of system 10 of the present invention will now be described. For the purposes of this description, reference will be made to the embodiment of the present invention depicted in FIG. 1. However, it will be appreciated that the discussion set forth herein also applies to the embodiment depicted in FIG. 4.
Sealing member 66 is removed from closure member 34, thereby exposing the interior of closure member 34. A medical professional can then access the contents of container 12 in one of two ways. First, the medical professional can withdraw fluid from container 12 using a sharp catheter, e.g., a hypodermic needle, by inserting the needle through needle access port 48 and piercing stopper 20. After insertion of the needle into container 12, fluid is drawn into the needle and the needle is withdrawn from stopper 20 through needle access port 48. Subsequent withdrawals of fluid from container 12 can be made using a needle by following the same sequence of steps.
In a second application of the system of the present invention, a medical professional will use a device having luer 63 mounted thereon.
Luer 63 is inserted into chamber 52. As above-discussed, inner wall 44 and wall 144 are preferably configured to provide a fluid-tight seal with the exterior surface of luer 63 when luer 63 is inserted therein. The medical professional then applies pressure to luer 63 such that it engages piercing member 54 and forces piercing member 54 toward container 12, thereby causing piercing tip 60 to penetrate stopper 20. Upon penetration of stopper 20 by piercing tip 60, the contents of container 12 are in fluid communication with piercing member 54 which in turn is in fluid communication with luer 63. If luer 63 and the exterior surfaces of inner wall 44/wall 144 are threaded, luer 63 can be threadably secured to inner wall 44/wall 144. The medical professional then can inject fluid into container 12 and/or withdraw fluid from container 12 through piercing member 54 by operation of luer 63 and a syringe attached thereto. When the injection into and/or withdrawal of fluid from container 12 has been completed, the luer 63 is withdrawn from inner wall 44, wall 144. As above-discussed, in the preferred embodiment of the present invention, stopper 20 and piercing member 54 preferably are constructed such that piercing member 54 is not withdrawn from stopper 20 when luer 63 is withdrawn from the inner wall 44/wall 144. In the event that piercing member 54 is withdrawn from stopper 20 during this procedure, piercing member retainer 64 will prevent piercing member 54 from being removed from chamber 52. The embodiment of the system of the present invention depicted in
FIG. 1 allows a medical professional to access the contents of container 12 using either a sharp cannula or a device having luer 63 mounted thereon. The embodiment of the system of the present invention depicted in FIG. 4 allows a medical professional to access the contents of container 12 using only a device having luer 63 mounted thereon. However, the embodiment of the system of the present invention depicted in FIG. 3 can be modified to include one or more needle access ports 48 defined by base 136 of closure member 134, thereby providing direct access to stopper 20.
Although the present invention has been disclosed herein with respect to certain preferred embodiments, it will be apparent to one of ordinary skill in the art that various modifications can be made to the system of the present invention. These modifications are intended to be within the scope of the present invention as claimed in the accompanying claims.

Claims

What is claimed is:
1. A container closure system comprising: a closure member configured to be attached to a container, said closure member comprising a base having an upper surface and a lower surface, said closure member further comprising an outer wall and an inner wall spaced from said outer wall, said outer wall and said inner wall extending from said upper surface of said base, said base defining therethrough a needle access port intermediate said inner and outer walls, said inner wall defining a chamber therein, said base defining therethrough an aperture adjacent said chamber defined by said inner wall; a stopper means for fluidly sealing said needle access port and said aperture defined by said base of said closure member; and a piercing member movably disposed within said chamber defined by said inner wall, said piercing member having a first end portion and a second end portion, said first end portion of said piercing member positioned proximally to said stopper means, a piercing tip mounted on said first end portion, said piercing tip constructed to pierce said stopper means, said second end portion constructed to engage a luer inserted into said chamber defined by said inner wall, said piercing member further defining a channel therethrough, said channel defined by said piercing member constructed to permit fluid transfer through said piercing member.
2. A container closure system in accordance with Claim 1, wherein said base of said closure member defines therethrough a plurality of needle access ports intermediate said inner and outer walls.
3. A container closure system in accordance with Claim 1, wherein said inner wall has an inner surface configured to engage frictionally a luer inserted into said chamber defined by said inner wall.
4. A container closure system in accordance with Claim 3, wherein said second end portion of said piercing member has a terminal end, and wherein said inner surface of said inner wall and said piercing member are configured such that said luer inserted into said chamber defined by said inner wall engages said terminal end of said piercing member in end-to-end abutment.
5. A container closure system in accordance with Claim 1, wherein said system further comprises a ferrule having a first leg and a second leg, said first leg engaging said closure member and said second leg configured to engage a container.
6. A container closure system in accordance with Claim 1, wherein said system further comprises a sealing member fluidly sealing said chamber defined by said inner wall from an external environment of said chamber.
7. A container closure system in accordance with Claim 6, wherein said closure member and said sealing member have mating threads formed thereon whereby said sealing member can be threadably secured to said closure member.
8. A container closure system in accordance with Claim 6, wherein said sealing member comprises a peelable membrane.
9. A container closure system comprising: a closure member configured to be attached to a container, said closure member comprising a base having an upper surface and a lower surface, said closure member further comprising a wall extending from said upper surface of said base, said wall defining a chamber therein, said base defining therethrough an aperture adjacent said chamber defined by said wall; a stopper means for fluidly sealing said aperture defined by said base of said closure member; and a piercing member movably disposed within said chamber defined by said wall, said piercing member having a first end portion and a second end portion, said first end portion of said piercing member positioned proximally to said stopper means, a piercing tip mounted on said first end portion, said piercing tip constructed to pierce said stopper means, said second end portion constructed to engage a luer inserted into said chamber defined by said wall, said piercing member further defining a channel therethrough, said channel defined by said piercing member constructed to provide fluid communication between said first end portion and said second end portion of said piercing member.
10. A container closure system in accordance with Claim
9, wherein said wall has an inner surface configured to engage frictionally a luer inserted into said chamber defined by said wall.
11. A container closure system in accordance with Claim
10, wherein said second end portion of said piercing member has a terminal end, and wherein said inner surface of said wall and said piercing member are configured such that said luer inserted into said chamber defined by said wall engages said terminal end of said piercing member in end-to-end abutment.
12. A container closure system in accordance with Claim 9, wherein said system further comprises a removable sealing member fluidly sealing said chamber defined by said wall from an external environment of said chamber.
13. A container closure system in accordance with Claim 12, wherein said sealing member comprises a peelable membrane.
14. A container closure system in accordance with Claim 9, wherein said system further comprises a ferrule having a first leg and a second leg, said first leg engaging said closure member and said second leg configured to engage a container, thereby retaining said closure member on the container.
15. A container closure system comprising: a stopper having an upper surface and a lower surface, said lower surface configured to seal fluidly an aperture of a container; a closure member mounted on said upper surface of said stopper, said closure member comprising a base having an upper surface and a lower surface, said closure member further comprising an outer wall and an inner wall spaced from said outer wall, said outer wall and said inner wall extending from said upper surface of said base, said lower surface of said base constructed to engage said upper surface of said stopper, said base defining therethrough a needle access port intermediate said inner and outer walls, said inner wall defining a chamber therein, said base defining therethrough an aperture adjacent said chamber defined by said inner wall; and a piercing member movably disposed within said chamber defined by said inner wall, said piercing member having a first end portion and a second end portion, said first end portion of said piercing member positioned proximally to said stopper, a piercing tip mounted on said first end portion, said piercing tip constructed to pierce said stopper, said second end portion constructed to engage a luer inserted into said chamber defined by said inner wall, said piercing member further defining a channel therethrough, said channel defined by said piercing member constructed to permit fluid transfer through said piercing member.
16. A container closure system in accordance with Claim 15, wherein said inner wall has an inner surface configured to engage frictionally a luer inserted into said chamber defined by said inner wall.
17. A container closure system in accordance with Claim 16, wherein said second end portion of said piercing member has a terminal end, and wherein said inner surface of said inner wall and said piercing member are configured such that a luer inserted into said chamber defined by said inner wall engages said terminal end of said piercing member in end-to-end abutment.
18. A container closure system comprising: a stopper having an upper surface and a lower surface, said lower surface constructed to seal fluidly a container; a closure member mounted on said upper surface of said stopper, said closure member comprising a base having an upper surface and a lower surface, said closure member further comprising a wall extending from said upper surface of said base, said lower surface of said base constructed to engage said upper surface of said stopper, said wall defining a chamber therein, said base defining therethrough an aperture adjacent said chamber defined by said wall; and a piercing member movably disposed within said chamber defined by said wall, said piercing member having a first end portion and a second end portion, said first end portion of said piercing member positioned proximally to said stopper, a piercing tip mounted on said first end portion, said piercing tip constructed to pierce said stopper, said second end portion constructed to engage a luer inserted into said chamber defined by said wall, said piercing member further defining a channel therethrough, said channel defined by said piercing member constructed to provide fluid communication between said first end portion and said second end portion of said piercing member.
19. A container closure system in accordance with Claim
18, wherein said wall has an inner surface configured to engage frictionally a luer inserted into said chamber defined by said wall.
20. A container closure system in accordance with Claim
19, wherein said second end portion of said piercing member has a terminal end, and wherein said inner surface of said wall and said piercing member are configured such that a luer inserted into said chamber defined by said wall engages said terminal end of said piercing member in end-to-end abutment.
21. A container closure system for use with a container sealed with a stopper, said system comprising: a closure member comprising a base having an upper surface and a lower surface, said closure member further comprising a wall extending from said upper surface of said base, said lower surface of said base constructed to engage a surface of a stopper sealing a container, said wall defining a chamber therein, said base defining an aperture therethrough adjacent said chamber defined by said wall, said wall having an inner surface configured to sealingly engage a luer inserted into said chamber defined by said wall; and a piercing member movably disposed within said chamber defined by said inner wall, said piercing member having a first end portion and a second end portion, said first end portion having mounted thereon a piercing tip constructed to pierce a stopper, said second end portion configured to engage a luer inserted into said chamber defined by said wall, said piercing member further defining a channel therethrough, said channel defined by said piercing member constructed to provide fluid communication from said first end portion to said second end portion of said piercing member.
PCT/US1997/005882 1996-04-22 1997-04-09 Container closure system WO1997039720A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU26627/97A AU720748B2 (en) 1996-04-22 1997-04-09 Container closure system
JP53811597A JP2000508934A (en) 1996-04-22 1997-04-09 Container sealing system
CA 2252404 CA2252404A1 (en) 1996-04-22 1997-04-09 Container closure system
EP19970918544 EP0895466A1 (en) 1996-04-22 1997-04-09 Container closure system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63610596A 1996-04-22 1996-04-22
US636,105 1996-04-22

Publications (1)

Publication Number Publication Date
WO1997039720A1 true WO1997039720A1 (en) 1997-10-30

Family

ID=24550458

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/005882 WO1997039720A1 (en) 1996-04-22 1997-04-09 Container closure system

Country Status (6)

Country Link
US (1) US6695829B2 (en)
EP (1) EP0895466A1 (en)
JP (1) JP2000508934A (en)
AU (1) AU720748B2 (en)
CA (1) CA2252404A1 (en)
WO (1) WO1997039720A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037854A1 (en) * 1997-02-28 1998-09-03 Abbott Laboratories Container cap assembly having an enclosed penetrator
US5925029A (en) * 1997-09-25 1999-07-20 Becton, Dickinson And Company Method and apparatus for fixing a connector assembly onto a vial with a crimp cap
WO1999053886A1 (en) * 1998-04-20 1999-10-28 Becton Dickinson And Company Plastic closure for vials and other medical containers
US6003566A (en) * 1998-02-26 1999-12-21 Becton Dickinson And Company Vial transferset and method
US6003702A (en) * 1995-09-27 1999-12-21 Becton Dickinson France, S.A. Vial with resealable connector assembly having a membrane and a multi-configuration fluid access device
EP0956849A3 (en) * 1998-05-04 2000-07-12 Bracco International B.V. Universal stopper
US6090093A (en) * 1997-09-25 2000-07-18 Becton Dickinson And Company Connector assembly for a vial having a flexible collar
EP1029526A1 (en) * 1997-11-07 2000-08-23 Bracco International B.V. Medicament container stopper with integral spike access means
WO2001003641A1 (en) * 1999-07-07 2001-01-18 Astrazeneca Ab Closure device for a medical container
US6213994B1 (en) 1997-09-25 2001-04-10 Becton Dickinson France, S.A. Method and apparatus for fixing a connector assembly onto a vial
EP1094012A2 (en) * 1999-10-20 2001-04-25 Becton, Dickinson and Company Plastic closure for vials and other medical containers
WO2001028490A1 (en) * 1999-10-20 2001-04-26 Becton Dickinson And Company Improved transfer set
JP2001145686A (en) * 1999-09-10 2001-05-29 Otsuka Pharmaceut Factory Inc Cap
US6681475B2 (en) 1998-04-20 2004-01-27 Becton Dickinson And Company Method of sealing a medical container with a plastic closure
EP3006063A1 (en) * 2014-09-15 2016-04-13 B. Braun Melsungen AG Closure assembly for a carrier housing of a medical fluid storage and/or conduit system

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4701483B2 (en) * 2000-08-25 2011-06-15 東洋製罐株式会社 Spout
FR2815328B1 (en) * 2000-10-17 2002-12-20 Biodome CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE
US6571971B1 (en) * 2001-02-08 2003-06-03 Weller Engineering, Inc. Hermetically sealed container with pierceable entry port
JP2003135563A (en) * 2001-11-02 2003-05-13 Nipro Corp Small bag-shaped medicine container
FR2836129B1 (en) 2002-02-20 2004-04-02 Biodome CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE
US6874522B2 (en) * 2002-06-18 2005-04-05 Baxter International Inc. Luer-actuated solution path connector with membrane and container using the connector and a method for establishing fluid communication with the container
AR040977A1 (en) * 2002-08-16 2005-04-27 Glaxosmithkline Biolog Sa CLOSURE PROVISION FOR A FLASK FOR PHARMACEUTICAL USE, THE FLASK, AND PROCEDURE FOR FILLING AND CLOSING
USD493526S1 (en) * 2003-04-22 2004-07-27 Becton, Dickinson And Company Syringe tip cap
GB0315953D0 (en) 2003-07-08 2003-08-13 Glaxosmithkline Biolog Sa Process
JP3883527B2 (en) * 2003-07-17 2007-02-21 ニプロ株式会社 Transfer needle
US20080009822A1 (en) * 2003-12-18 2008-01-10 Halkey-Roberts Corporation Needleless access vial
NZ548279A (en) * 2003-12-18 2009-02-28 Halkey Roberts Corp Needleless access vial
WO2005087127A1 (en) * 2004-02-13 2005-09-22 Paradis Joeseph R Swabbable needleless vial access
IL161660A0 (en) 2004-04-29 2004-09-27 Medimop Medical Projects Ltd Liquid drug delivery device
FR2873520B1 (en) * 2004-07-20 2006-10-13 Frederic Aberlenc HIGH CAPACITANCE MONITORING SYSTEM
BRPI0518070A (en) * 2004-10-27 2008-10-28 Glaxosmithkline Biolog Sa process for preparing a lyophilized material and apparatus suitable for use therein.
US7396051B2 (en) * 2005-01-14 2008-07-08 Baxa Corporation Swabable fluid connectors and fluid connector pairs
GB0510057D0 (en) 2005-05-17 2005-06-22 Glaxosmithkline Biolog Sa Novel device
ES2371557T3 (en) 2005-08-11 2012-01-05 Medimop Medical Projects Ltd. TRANSFER DEVICES OF LIQUID DRUGS FOR A RIGHT PRESSURE ADJUSTMENT TO FAILURE IN MEDICINAL ROADS.
US20070141204A1 (en) * 2005-12-15 2007-06-21 Xiong Wade W Beverage systems
US20090004343A1 (en) * 2005-12-15 2009-01-01 Xiong Wade W Beverage systems
GB0604591D0 (en) * 2006-03-07 2006-04-19 Glaxosmithkline Biolog Sa Novel device
EP2540276B1 (en) 2006-05-25 2016-03-16 Bayer Healthcare LLC Method of assembling a reconstitution device
CN101528180B (en) * 2006-10-17 2012-09-26 株式会社Jms Communication member and medical container using the same
IL182605A0 (en) 2007-04-17 2007-07-24 Medimop Medical Projects Ltd Fluid control device with manually depressed actuator
US8151985B2 (en) * 2007-06-22 2012-04-10 Owoc Greg J Containers for storing at least two substances for subsequent mixing
WO2009038860A2 (en) 2007-09-18 2009-03-26 Medeq Llc Medicament mixing and injection apparatus
IL186290A0 (en) * 2007-09-25 2008-01-20 Medimop Medical Projects Ltd Liquid drug delivery devices for use with syringe having widened distal tip
US8864725B2 (en) 2009-03-17 2014-10-21 Baxter Corporation Englewood Hazardous drug handling system, apparatus and method
IL201323A0 (en) * 2009-10-01 2010-05-31 Medimop Medical Projects Ltd Fluid transfer device for assembling a vial with pre-attached female connector
IL202070A0 (en) 2009-11-12 2010-06-16 Medimop Medical Projects Ltd Inline liquid drug medical device
IL202069A0 (en) 2009-11-12 2010-06-16 Medimop Medical Projects Ltd Fluid transfer device with sealing arrangement
US9296531B2 (en) * 2010-01-12 2016-03-29 Medela Holding Ag Container with sealed cap and venting system
CN102781396B (en) 2010-02-24 2015-01-07 麦迪麦珀医疗工程有限公司 Liquid drug transfer device with vented vial adapter
WO2011104711A1 (en) 2010-02-24 2011-09-01 Medimop Medical Projects Ltd Fluid transfer assembly with venting arrangement
USD669980S1 (en) 2010-10-15 2012-10-30 Medimop Medical Projects Ltd. Vented vial adapter
IL209290A0 (en) 2010-11-14 2011-01-31 Medimop Medical Projects Ltd Inline liquid drug medical device having rotary flow control member
IL212420A0 (en) 2011-04-17 2011-06-30 Medimop Medical Projects Ltd Liquid drug transfer assembly
IL215699A0 (en) 2011-10-11 2011-12-29 Medimop Medical Projects Ltd Liquid drug reconstitution assemblage for use with iv bag and drug vial
USD737436S1 (en) 2012-02-13 2015-08-25 Medimop Medical Projects Ltd. Liquid drug reconstitution assembly
USD674088S1 (en) 2012-02-13 2013-01-08 Medimop Medical Projects Ltd. Vial adapter
USD720451S1 (en) 2012-02-13 2014-12-30 Medimop Medical Projects Ltd. Liquid drug transfer assembly
IL219065A0 (en) 2012-04-05 2012-07-31 Medimop Medical Projects Ltd Fluid transfer device with manual operated cartridge release arrangement
IL221635A0 (en) 2012-08-26 2012-12-31 Medimop Medical Projects Ltd Drug vial mixing and transfer device for use with iv bag and drug vial
IL221634A0 (en) 2012-08-26 2012-12-31 Medimop Medical Projects Ltd Universal drug vial adapter
EP2872100B1 (en) 2012-09-13 2017-03-29 Medimop Medical Projects Ltd Telescopic female drug vial adapter
USD734868S1 (en) 2012-11-27 2015-07-21 Medimop Medical Projects Ltd. Drug vial adapter with downwardly depending stopper
US9492350B2 (en) 2013-03-14 2016-11-15 Baxter International Inc. Dialysis bag with anti-occlusion feature
IL225734A0 (en) 2013-04-14 2013-09-30 Medimop Medical Projects Ltd Ready-to-use drug vial assemblages including drug vial and drug vial closure having fluid transfer member, and drug vial closure therefor
CN105228676B (en) 2013-05-10 2018-01-05 麦迪麦珀医疗工程有限公司 Include the medical treatment device of the vial adapter with inline dry kit
USD767124S1 (en) 2013-08-07 2016-09-20 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
CN205626622U (en) 2013-08-07 2016-10-12 麦迪麦珀医疗工程有限公司 Liquid transfer device that is used together with infusion container
USD765837S1 (en) 2013-08-07 2016-09-06 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
EP3064238A4 (en) * 2013-10-31 2017-09-27 Daiwa Can Company Syringe container
USD757933S1 (en) 2014-09-11 2016-05-31 Medimop Medical Projects Ltd. Dual vial adapter assemblage
BR112017013534B1 (en) 2015-01-05 2021-12-21 Medimop Medical Projects Ltd. ASSEMBLING THE DOUBLE BOTTLE ADAPTER FOR USE WITH ONE MEDICATION BOTTLE AND ONE LIQUID BOTTLE
CN113143759B (en) 2015-07-16 2024-01-30 西部制药服务以色列有限公司 Liquid drug transfer device for secure telescopic snap-fit on an injection vial
USD801522S1 (en) 2015-11-09 2017-10-31 Medimop Medical Projects Ltd. Fluid transfer assembly
JP6523569B2 (en) 2015-11-25 2019-06-05 ウエスト・ファーマ.サービシーズ・イスラエル,リミテッド Dual vial adapter assembly comprising a vial adapter having a self sealing access valve
US10494153B2 (en) * 2016-02-16 2019-12-03 Vection, Ltd. Method and apparatus for controlled transfer of fluid
US11077994B2 (en) 2016-02-16 2021-08-03 Vection Limited Method and apparatus for controlled transfer of fluid
IL245803A0 (en) 2016-05-24 2016-08-31 West Pharma Services Il Ltd Dual vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter
IL245800A0 (en) 2016-05-24 2016-08-31 West Pharma Services Il Ltd Dual vial adapter assemblages including identical twin vial adapters
IL246073A0 (en) 2016-06-06 2016-08-31 West Pharma Services Il Ltd Fluid transfer devices for use with drug pump cartridge having slidable driving plunger
IL247376A0 (en) 2016-08-21 2016-12-29 Medimop Medical Projects Ltd Syringe assembly
USD832430S1 (en) 2016-11-15 2018-10-30 West Pharma. Services IL, Ltd. Dual vial adapter assemblage
IL249408A0 (en) 2016-12-06 2017-03-30 Medimop Medical Projects Ltd Liquid transfer device for use with infusion liquid container and pincers-like hand tool for use therewith for releasing intact drug vial therefrom
IL251458A0 (en) 2017-03-29 2017-06-29 Medimop Medical Projects Ltd User actuated liquid drug transfer devices for use in ready-to-use (rtu) liquid drug transfer assemblages
IL254802A0 (en) 2017-09-29 2017-12-31 Medimop Medical Projects Ltd Dual vial adapter assemblages with twin vented female vial adapters
USD903864S1 (en) 2018-06-20 2020-12-01 West Pharma. Services IL, Ltd. Medication mixing apparatus
JP1630477S (en) 2018-07-06 2019-05-07
USD923812S1 (en) 2019-01-16 2021-06-29 West Pharma. Services IL, Ltd. Medication mixing apparatus
JP1648075S (en) 2019-01-17 2019-12-16
WO2020157719A1 (en) 2019-01-31 2020-08-06 West Pharma. Services Il, Ltd Liquid transfer device
CA3135248C (en) 2019-04-30 2024-01-02 Yossi Bar-El Liquid transfer device with dual lumen iv spike
KR20220163363A (en) * 2020-02-13 2022-12-09 웨스트 파마수티컬 서비시즈, 인코포레이티드 Containment and delivery systems for cryogenic storage
USD956958S1 (en) 2020-07-13 2022-07-05 West Pharma. Services IL, Ltd. Liquid transfer device
CN118043017A (en) * 2021-09-30 2024-05-14 康宁公司 Glass container for storing pharmaceutical compositions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3336924A (en) * 1964-02-20 1967-08-22 Sarnoff Two compartment syringe package
FR2256752A1 (en) * 1974-05-07 1975-08-01 Larson Roger
FR2560049A1 (en) * 1984-02-24 1985-08-30 Erba Farmitalia SAFETY DEVICE FOR CONNECTING A SYRINGE WITH THE OPENING OF A BOTTLE CONTAINING A MEDICINAL PRODUCT OR A SMALL TUBE FOR PROVIDING A MEDICAMENT FROM THE SYRINGE
EP0458543A1 (en) * 1990-05-25 1991-11-27 Dbl Inc. Suction transfer assembly
US5423791A (en) * 1992-03-31 1995-06-13 Bartlett; J. Mark Valve device for medical fluid transfer
US5425465A (en) * 1993-03-03 1995-06-20 Healy; Patrick M. Valved medication container
EP0765652A1 (en) * 1995-09-27 1997-04-02 Becton, Dickinson and Company Reseable vial with connector assembly having a membrane and pusher

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2342215A (en) 1942-08-03 1944-02-22 Harold N Perelson Dispensing and sealing stopper
US2388634A (en) 1944-12-07 1945-11-06 Ace Glass Inc Container for aseptic filling and dispensing of sterile liquids
US2524365A (en) 1947-12-12 1950-10-03 Arthur E Smith Closure
US2608972A (en) 1948-02-23 1952-09-02 Chrigstrom Knut Vilhelm Guide for hypodermic syringes
US2659370A (en) 1950-08-26 1953-11-17 Arthur E Smith Closure
US2667986A (en) 1951-12-22 1954-02-02 Harold N Perelson Self-sealing dispensing device
ES370617A1 (en) 1968-08-28 1971-05-01 Pfizer Dual-chamber liquid ejector and filling connector
US3826260A (en) 1971-12-27 1974-07-30 Upjohn Co Vial and syringe combination
US3810469A (en) 1972-05-24 1974-05-14 Ampoules Inc Multiple compartment hypodermic devices
US3872992A (en) 1973-08-06 1975-03-25 Pharmaco Inc Medicament vial stopper piercing and needle positioning device
US3977555A (en) 1974-05-07 1976-08-31 Pharmaco, Inc. Protective safety cap for medicament vial
NL173477C (en) 1974-09-12 1984-02-01 Duphar Int Res INJECTION SYRINGE WITH TELESCOPIC BODY BETWEEN CARTRIDGE AND MEDICINE BOTTLE.
FR2311727A1 (en) 1975-05-21 1976-12-17 Tuboplast France PACKAGING CONTAINER FOR EXTEMPORARY PREPARATION OF MULTI-COMPONENT SOLUTIONS
US4153057A (en) 1975-07-24 1979-05-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Stopper for two-chamber mixing syringe
DE2533036A1 (en) 1975-07-24 1977-02-10 Merck Patent Gmbh Syringe and container assembly for mixing medical injections - is sterile, inexpensive, disposable and easily operated
DE3104861A1 (en) 1981-02-11 1982-08-26 Milupa Ag, 6382 Friedrichsdorf SUCTION BOTTLE
US4493348A (en) 1981-06-29 1985-01-15 Pur/Acc Corporation Method and apparatus for orally dispensing liquid medication
US4624393A (en) 1981-07-02 1986-11-25 Survival Technology, Inc. Split hub assembly for a necked down cartridge tube
DE3152033A1 (en) 1981-12-31 1983-07-07 Alfred Von 4178 Kevelaer Schuckmann Container for the sterile transfer of drugs
US4507113A (en) 1982-11-22 1985-03-26 Derata Corporation Hypodermic jet injector
US4505709A (en) 1983-02-22 1985-03-19 Froning Edward C Liquid transfer device
SE434700B (en) 1983-05-20 1984-08-13 Bengt Gustavsson DEVICE FOR AIRED TRANSFER OF SUBSTANCE FROM A KERLE TO ANOTHER
EP0126718A3 (en) * 1983-05-20 1985-10-23 Bengt Gustavsson A device for transferring a substance from one vessel to another and further to the intended application
US4619651A (en) * 1984-04-16 1986-10-28 Kopfer Rudolph J Anti-aerosoling drug reconstitution device
US5088996A (en) 1984-04-16 1992-02-18 Kopfer Rudolph J Anti-aerosoling drug reconstitution device
US4588403A (en) 1984-06-01 1986-05-13 American Hospital Supply Corporation Vented syringe adapter assembly
US4675020A (en) 1985-10-09 1987-06-23 Kendall Mcgaw Laboratories, Inc. Connector
US4662878A (en) 1985-11-13 1987-05-05 Patents Unlimited Ltd. Medicine vial adaptor for needleless injector
DE8532615U1 (en) 1985-11-19 1986-01-02 Badenhausen, Ludwig, 4270 Dorsten Aid to draw up liquid medication using a syringe
SE451942B (en) 1986-02-26 1987-11-09 Broden Bengt Inge DEVICE FOR HANDLING ORGANIC BODY WELDINGS
IE60235B1 (en) 1986-09-18 1994-06-15 Kabi Pharmacia Ab "Connector and disposable assembly utilising said connector"
ATE66806T1 (en) 1986-11-06 1991-09-15 Bengt Gustavsson CONTAINERS FOR STORAGE OR COLLECTION OF LIQUIDS AND DRY SUBSTANCES.
US5178607A (en) 1987-07-31 1993-01-12 Lynn Lawrence A Blood aspiration assembly septum and blunt needle aspirator
IT1231892B (en) 1987-10-14 1992-01-15 Farmitalia Carlo Erba S P A Mi APPARATUS WITH SAFETY LOCKING ORGANS FOR CONNECTION OF A SYRINGE TO A BOTTLE CONTAINING A DRUG
US5411499A (en) 1988-01-25 1995-05-02 Baxter International Inc. Needleless vial access device
DE3806875C1 (en) * 1988-03-03 1989-11-16 Franz Pohl, Metall- Und Kunststoffwarenfabrik Gmbh, 7500 Karlsruhe, De
US5275299A (en) 1988-04-15 1994-01-04 C. A. Greiner & Sohne Gesellschaft Mbh Closure device for an in particular evacuable cylindrical housing
US5514117A (en) 1988-09-06 1996-05-07 Lynn; Lawrence A. Connector having a medical cannula
DE68917930T2 (en) 1988-09-30 1995-03-30 Utterberg David S NEEDLE UNIT WITH A PROTECTIVE AND FASTENING DEVICE.
CA2006584C (en) 1988-12-27 1998-11-10 Gabriel Meyer Storage and transfer bottle for storing a component of a medicinal substance
US5169385A (en) 1989-01-26 1992-12-08 Turnbull Christopher J Safety I. V. drug introducer set
US5035689A (en) 1989-03-13 1991-07-30 Schroeder Thomas J Luer-loc-tipped vial--syringe combination
AU5975490A (en) 1989-08-24 1991-02-28 International Medication Systems Limited Protective sheath for a cannula
DE69003805T2 (en) 1989-11-13 1994-05-19 Becton Dickinson France STORAGE CONTAINER FOR A COMPONENT OF A MEDICINAL SOLUTION.
US5409125A (en) 1989-12-11 1995-04-25 Aktiebolaget Astra Unit dose container
US5024256A (en) 1990-04-02 1991-06-18 Vadher Dinesh L Vial construction and method
US5092840A (en) 1990-07-16 1992-03-03 Healy Patrick M Valved medicine container
US5060812A (en) 1990-09-06 1991-10-29 International Medication Systems, Limited Medication container stopper which can be punctured by nozzle of a hypodermic syringe
US5232029A (en) 1990-12-06 1993-08-03 Abbott Laboratories Additive device for vial
WO1992011056A1 (en) 1990-12-18 1992-07-09 University Of Florida Fluid transfer device and method of use
GB9103291D0 (en) 1991-02-15 1991-04-03 Waverley Pharma Ltd Transfer adaptor
SG46491A1 (en) 1991-03-19 1998-02-20 Hoffmann La Roche Closure for reagent container
JPH0611738U (en) * 1991-08-23 1994-02-15 昭和電工株式会社 Medical bag
CA2117088A1 (en) 1991-09-05 1993-03-18 David R. Holmes Flexible tubular device for use in medical applications
US5360413A (en) 1991-12-06 1994-11-01 Filtertek, Inc. Needleless access device
US5474541A (en) 1992-01-10 1995-12-12 Astra Pharma, Inc. Valved nozzle for re-usable reservoir of a flowable product
US5215538A (en) 1992-02-05 1993-06-01 Abbott Laboratories Connector-activated in-line valve
US5279576A (en) 1992-05-26 1994-01-18 George Loo Medication vial adapter
CZ29095A3 (en) 1992-08-07 1995-07-12 West Co Closing device for little containers, particularly for medicaments, for providing access without need of needle
GB2270725B (en) 1992-09-07 1995-08-02 Bespak Plc Connecting apparatus for medical conduits
US5344417A (en) 1992-09-11 1994-09-06 Becton, Dickinson And Company Universal fitting for inoculation receptacles
US5376073A (en) 1992-11-23 1994-12-27 Becton, Dickinson And Company Locking safety needle assembly
US5356406A (en) 1993-01-08 1994-10-18 Steven Schraga Adaptor to facilitate interconnection of medicine bottle and syringe
US5364386A (en) 1993-05-05 1994-11-15 Hikari Seiyaku Kabushiki Kaisha Infusion unit
US5421814A (en) 1993-06-03 1995-06-06 Innovations For Access, Inc. Hemodialysis infusion port and access needle
CA2124970A1 (en) 1993-06-29 1994-12-30 R. Hayes Helgren Pointed adapter for blunt entry device
US5429614A (en) 1993-06-30 1995-07-04 Baxter International Inc. Drug delivery system
US5397303A (en) 1993-08-06 1995-03-14 River Medical, Inc. Liquid delivery device having a vial attachment or adapter incorporated therein
US5342319A (en) 1993-08-17 1994-08-30 Watson Robert L Transdermal injection appliance
AU1290895A (en) 1993-11-19 1995-06-06 Cross Medical Products, Inc. Self-locking set screw for spinal fixation system
AU1332795A (en) 1993-11-30 1995-06-19 Medex, Inc. Plastic needleless valve housing for standard male luer locks
WO1995017874A1 (en) 1993-12-28 1995-07-06 Thomas Lee Watson Bottle with closure element for receiving a syringe
US5429256A (en) * 1994-01-24 1995-07-04 Kestenbaum; Alan D. Drug withdrawal system for container
US5620434A (en) 1994-03-14 1997-04-15 Brony; Seth K. Medicine vial link for needleless syringes
US5454805A (en) 1994-03-14 1995-10-03 Brony; Seth K. Medicine vial link for needleless syringes
IT233201Y1 (en) 1994-03-24 2000-01-26 Bracco Spa TWO-COMPONENT DEVICE FOR THE ADMINISTRATION OF DRUGS
DE4416656C2 (en) 1994-05-11 1997-03-13 Vetter & Co Apotheker Device for creating a venous access
US5474544A (en) 1994-05-25 1995-12-12 Lynn; Lawrence A. Luer-receiving medical valve
JP3456019B2 (en) * 1994-06-17 2003-10-14 ニプロ株式会社 Liquid introduction needle and aid for dissolving dry preparation using the same
US5470319A (en) 1994-06-20 1995-11-28 Critical Device Corporation Needleless injection site
US5616130A (en) 1994-06-20 1997-04-01 Nima Enterprises, Inc. Needleless injection site
US5415374A (en) 1994-07-18 1995-05-16 Sloan Valve Company Flush valve improvements for controlling flushing volume
US5514116A (en) 1994-10-24 1996-05-07 Vlv Associates Connector
US5549566A (en) 1994-10-27 1996-08-27 Abbott Laboratories Valved intravenous fluid line infusion device
US5520666A (en) 1994-12-06 1996-05-28 Abbott Laboratories Valved intravenous fluid line connector
US5501676A (en) 1995-01-13 1996-03-26 Sanofi Winthrop, Inc. Coupling system for safety cannula
US5573526A (en) 1995-05-08 1996-11-12 Minntech Corporation Soft shell reservoir
FR2738550B1 (en) 1995-09-11 1997-11-07 Biodome DEVICE FOR SEALING A CONTAINER ITSELF CLOSED, ASSEMBLY FOR PROVIDING A PRODUCT COMPRISING SUCH A CONTAINER AND SUCH A SEALING DEVICE
US6513650B2 (en) * 1997-10-14 2003-02-04 Biogaia Ab Two-compartment container
US6499617B1 (en) * 2000-07-17 2002-12-31 Brocco Diagnostics, Inc. Rotary seal stopper

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3336924A (en) * 1964-02-20 1967-08-22 Sarnoff Two compartment syringe package
FR2256752A1 (en) * 1974-05-07 1975-08-01 Larson Roger
FR2560049A1 (en) * 1984-02-24 1985-08-30 Erba Farmitalia SAFETY DEVICE FOR CONNECTING A SYRINGE WITH THE OPENING OF A BOTTLE CONTAINING A MEDICINAL PRODUCT OR A SMALL TUBE FOR PROVIDING A MEDICAMENT FROM THE SYRINGE
EP0458543A1 (en) * 1990-05-25 1991-11-27 Dbl Inc. Suction transfer assembly
US5423791A (en) * 1992-03-31 1995-06-13 Bartlett; J. Mark Valve device for medical fluid transfer
US5425465A (en) * 1993-03-03 1995-06-20 Healy; Patrick M. Valved medication container
EP0765652A1 (en) * 1995-09-27 1997-04-02 Becton, Dickinson and Company Reseable vial with connector assembly having a membrane and pusher

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6003702A (en) * 1995-09-27 1999-12-21 Becton Dickinson France, S.A. Vial with resealable connector assembly having a membrane and a multi-configuration fluid access device
WO1998037854A1 (en) * 1997-02-28 1998-09-03 Abbott Laboratories Container cap assembly having an enclosed penetrator
US5925029A (en) * 1997-09-25 1999-07-20 Becton, Dickinson And Company Method and apparatus for fixing a connector assembly onto a vial with a crimp cap
US6213994B1 (en) 1997-09-25 2001-04-10 Becton Dickinson France, S.A. Method and apparatus for fixing a connector assembly onto a vial
US6090093A (en) * 1997-09-25 2000-07-18 Becton Dickinson And Company Connector assembly for a vial having a flexible collar
EP1029526A1 (en) * 1997-11-07 2000-08-23 Bracco International B.V. Medicament container stopper with integral spike access means
US6003566A (en) * 1998-02-26 1999-12-21 Becton Dickinson And Company Vial transferset and method
US6378714B1 (en) * 1998-04-20 2002-04-30 Becton Dickinson And Company Transferset for vials and other medical containers
US6601721B2 (en) 1998-04-20 2003-08-05 Becton, Dickinson And Company Transferset for vials and other medical containers
JP4669038B2 (en) * 1998-04-20 2011-04-13 ベクトン・ディキンソン・アンド・カンパニー Plastic closures for bottles and other medical containers
JP2010075723A (en) * 1998-04-20 2010-04-08 Becton Dickinson & Co Plastic closure for vials and other medical containers
JP2009107726A (en) * 1998-04-20 2009-05-21 Becton Dickinson & Co Plastic closure body for bottle and other medical container
WO1999053886A1 (en) * 1998-04-20 1999-10-28 Becton Dickinson And Company Plastic closure for vials and other medical containers
US6382442B1 (en) * 1998-04-20 2002-05-07 Becton Dickinson And Company Plastic closure for vials and other medical containers
US6681475B2 (en) 1998-04-20 2004-01-27 Becton Dickinson And Company Method of sealing a medical container with a plastic closure
AU760384B2 (en) * 1998-04-20 2003-05-15 Becton Dickinson & Company Plastic closure for vials and other medical containers
EP0956849A3 (en) * 1998-05-04 2000-07-12 Bracco International B.V. Universal stopper
AU770228B2 (en) * 1999-07-07 2004-02-19 Astrazeneca Ab Closure device for a medical container
WO2001003641A1 (en) * 1999-07-07 2001-01-18 Astrazeneca Ab Closure device for a medical container
JP2001145686A (en) * 1999-09-10 2001-05-29 Otsuka Pharmaceut Factory Inc Cap
JP2003511212A (en) * 1999-10-20 2003-03-25 ベクトン・ディキンソン・アンド・カンパニー Transfer sets for vials and other medical containers
JP2003511319A (en) * 1999-10-20 2003-03-25 ベクトン・ディキンソン・アンド・カンパニー Improved transfer set
EP1094012A3 (en) * 1999-10-20 2002-06-19 Becton, Dickinson and Company Plastic closure for vials and other medical containers
AU782098B2 (en) * 1999-10-20 2005-06-30 Becton Dickinson & Company Improved transfer set
WO2001028489A1 (en) * 1999-10-20 2001-04-26 Becton Dickinson And Company Transfer set for vials and other medical containers
WO2001028490A1 (en) * 1999-10-20 2001-04-26 Becton Dickinson And Company Improved transfer set
EP1094012A2 (en) * 1999-10-20 2001-04-25 Becton, Dickinson and Company Plastic closure for vials and other medical containers
JP4686091B2 (en) * 1999-10-20 2011-05-18 ベクトン・ディキンソン・アンド・カンパニー Improved transfer set
JP2012152592A (en) * 1999-10-20 2012-08-16 Becton Dickinson & Co Transfer set for vials and other medical container
JP2014237014A (en) * 1999-10-20 2014-12-18 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Transfer set for vial and other medical container
EP3006063A1 (en) * 2014-09-15 2016-04-13 B. Braun Melsungen AG Closure assembly for a carrier housing of a medical fluid storage and/or conduit system

Also Published As

Publication number Publication date
AU2662797A (en) 1997-11-12
US20010000347A1 (en) 2001-04-19
JP2000508934A (en) 2000-07-18
CA2252404A1 (en) 1997-10-30
EP0895466A1 (en) 1999-02-10
US6695829B2 (en) 2004-02-24
AU720748B2 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
US6695829B2 (en) Container closure system
EP0551465B1 (en) Needleless vial access device
US4599082A (en) Two-component syringe assembly
US5832971A (en) Syringe filling and delivery device
US5807374A (en) Syringe filling and delivery device
US5454409A (en) Transfer adaptors
US5746733A (en) Syringe filling and delivery device
US4392850A (en) In-line transfer unit
CA2221434C (en) Syringe filling and delivery device
EP0896826B1 (en) Syringe filling and delivery device
EP1205173B1 (en) Safety device for a syringe assembly
EP1029526B1 (en) Medicament container stopper with integral spike access means
AU2021209845B2 (en) Vial adapter device
EP0820779B1 (en) Syringe filling and delivery device
KR19980079298A (en) Syringe Filling and Carrying Device
JPH03133456A (en) Device for storing, preparing and using drug
MXPA97007012A (en) A transfer assembly for a medicinal container that has a valve without spark
MXPA97005521A (en) Filling and supply device of jeri

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2252404

Country of ref document: CA

Ref country code: CA

Ref document number: 2252404

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997918544

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997918544

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997918544

Country of ref document: EP